ArticleCell death & disease2019

TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription.

Weiwei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.